2026 Lecture

The opening arc of the 2026 course: from what makes analysis a science, to what that means inside a company that discovers, develops, and sells medicines, to the regulations that govern it all.

This is the opening arc of the 2026 course. It moves deliberately in one direction — science → pharma → regs: first why pharmaceutical analysis is a science, then what that science is for inside a company that has to discover, develop, and sell a medicine, then the regulations that govern every analytical decision.

Work through the sections below in order. Use the menu on the left to see where you are, and the “On this page” list on the right to move within a section.


Pharmaceutical Analysis Is Science — From STEM to STEAM

The opening frame for the 2026 course: why pharmaceutical analysis is a science in the full sense of the word, and what the ‘A’ in STEAM adds to it.

Pharmaceutical Analysis in a Regulated Organization

What STEM-to-STEAM looks like once it’s inside a company that has to discover, develop, and ultimately sell a novel medicine — and the science → pharma → regs funnel this course follows.

Regulations & Compendial Methods

The ‘regs’ end of the funnel: how ICH guidelines, the pharmacopeias, and agency expectations shape every analytical decision — from method design to release.